ARCHIVES

Phase III Study: Lymphoseek Superior to Vital Blue Dye

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

DCE Concepts Statements

March 11, 1988

Shift Of $6.5 Million From Contracts to Pay Core, P01s At Recommended Levels, Increase R01 Payline

June 27, 1980

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

DRCCA Board Okays Chemoprevention RFA, Referral Guidelines

January 29, 1982

Senators Urge study section On Clinical Cancer Research

February 4, 1994

New CEO Brings Managed Care Expertise To Network Of Academic Cancer Centers

January 24, 1997